Categories: DataHealthTechInvestmentLifePersonalProductResearchScienceTechnologyUniversity
Clasp Therapeutics aims to bring absolute precision to immuno-oncology by developing next-generation T cell engagers (TCEs) that target tumor-specific oncogenic driver mutations across hard-to-treat cancers. Clasp is developing T cell engagers to match both the specific characteristics of the patient’s immune system and the specific genetics of their tumor, enabling the creation of exquisitely personalized, yet off-the-shelf, therapeutics. Built upon academic research in the labs of Bert Vogelstein and Drew Pardoll at Johns Hopkins University, Clasp is backed by prominent life sciences investors including Catalio Capital Management, Third Rock Ventures and Novo Holdings. The company was launched in March 2024 and is based in Cambridge, MA and Rockville, MD. For more information about Clasp, please visit www.clasptx.com
Investors 4
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.05.2024 | Series A | $150M | - |
Mentions in press and media 4
| Date | Title | Description |
| 05.05.2024 | Clasp Therapeutics Grabs $150M Series A Funding |
ROCKVILLE, MD, Clasp Therapeutics, a biotechnology company, has raised $150 million in financing.
>> Click here for more funding data on Clasp Therapeutics
>> To export Clasp Therapeutics funding data to PDF and Excel, click he... |
| 20.03.2024 | Clasp Therapeutics Raises $150M in Funding | Clasp Therapeutics, a Cambridge, MA-based biotechnology company that develops immuno-oncology therapies using T cell engagers (TCEs), raised $150M in funding.
The round was led by Catalio Capital Management, Third Rock Ventures and Novo Hol... |
| 20.03.2024 | Third Rock, Novo Holdings-backed Clasp Tx hooks $150M series A for next-gen cancer treatments | A new immuno-oncology biotech has emerged, clasping $150 million that will go toward developing next-generation T cell engagers (TCEs) targeting a range of hard-to-treat tumors.
Clasp Therapeutics unveiled March 20, touting a series A co-le... |
| - | Clasp Therapeutics | “Clasp Tx” |
Reviews 0
